Software group Instem PLC (AIM:INS) said it has no exposure to Silicon Valley Bank.
The lender’s collapse has affected a number of UK technology and biotechnology groups.
Instem, which develops technology used to monitor drug trials, told investors: “The company does not hold any cash at SVB and it does not have a banking relationship with or any exposure to SVB.”